WA
GILD icon

Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,000
Closed -$5K – 85
2020
Q3 		$5K Hold
10,000
– – ﹤0.01% 80
2020
Q2 		$56K Buy
+10,000
New +$766K 0.03% 72

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Wealth Advisors's GILD Position: Q3 2023 in Review

Wealth Advisors held its Gilead Sciences (GILD) position steady in Q3 2023 at 3,140 shares worth $235K. The position accounts for 0.11% of the portfolio, ranked #59.

Wealth Advisors first reported a position in GILD in Q1 2020 and has held it in 11 quarters since. The position peaked at $270K in Q4 2022. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • Wealth Advisors held 3,140 shares of Gilead Sciences worth $235K as of Q3 2023.
  • Wealth Advisors left its Gilead Sciences share count unchanged in Q3 2023.
  • Gilead Sciences made up 0.11% of Wealth Advisors's portfolio in Q3 2023, its #59 holding.
  • Wealth Advisors first reported a position in Gilead Sciences in Q1 2020 and has held it in 11 quarters since.
  • Wealth Advisors's Gilead Sciences position peaked at $270K in Q4 2022.
  • 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Wealth Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.